Last update 01 Nov 2024

NXP-800

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
N-[5-(2,3-Dihydrobenzo[b][1,4]dioxine-6-carboxamido)-2-fluorophenyl]-2-[(4-ethylpiperazin-1-yl)methyl]quinoline-6-carboxamide
+ [3]
Target
Mechanism
EIF2AK4 stimulants(eukaryotic translation initiation factor 2 alpha kinase 4 stimulants)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
RegulationFast Track (US), Orphan Drug (US)
Login to view timeline

Structure

Molecular FormulaC32H32FN5O4
InChIKeyUBALMDIKIGDHJW-UHFFFAOYSA-N
CAS Registry1693734-80-3

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Clear cell neoplasm of ovaryPhase 1
GB
31 Dec 2021
Clear cell neoplasm of ovaryPhase 1
US
31 Dec 2021
Endometrioid carcinoma ovaryPhase 1
US
31 Dec 2021
Endometrioid carcinoma ovaryPhase 1
GB
31 Dec 2021
Ovarian clear cell adenocarcinomaPhase 1
GB
31 Dec 2021
Ovarian clear cell adenocarcinomaPhase 1
US
31 Dec 2021
Bile Duct NeoplasmsPhase 1
US
-
Platinum-Resistant, ARID1A-Mutated Ovarian CarcinomaPreclinical
US
31 Dec 2021
Platinum-Resistant, ARID1A-Mutated Ovarian CarcinomaPreclinical
GB
31 Dec 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
18
NXP800 50 mg/day
(xzhxippknm) = jereabcvrm jnxkuhfqxb (llfehzsktx )
Positive
05 Apr 2024
NXP800 75 mg/day
(llyctfakyt) = cexctknxef fygoeuwayc (sdciongfvj )
Phase 1
3
(sburrwawvx) = uubndffkdt esusnzvbwu (gutvyldumn )
Positive
14 Mar 2024
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free